EZZ Life Science Holdings Ltd. (AU:EZZ)
ASX:EZZ
Total Valuation
EZZ Life Science Holdings Ltd. has a market cap or net worth of AU$38.10M. The enterprise value is AU$26.17M.
Market CapAU$38.10M
Enterprise ValueAU$26.17M
Share Statistics
EZZ Life Science Holdings Ltd. has 47,043,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding47,043,200
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
EZZ Life Science Holdings Ltd.’s return on equity (ROE) is 0.24 and return on invested capital (ROIC) is 21.89%.
Return on Equity (ROE)0.24
Return on Assets (ROA)0.20
Return on Invested Capital (ROIC)21.89%
Return on Capital Employed (ROCE)0.35
Revenue Per Employee6.08M
Profits Per Employee0.00
Employee Count11
Asset Turnover1.97
Inventory Turnover7.05
Valuation Ratios
The current PE Ratio of EZZ Life Science Holdings Ltd. is ―. EZZ Life Science Holdings Ltd.’s PEG ratio is -2.57.
PE Ratio―
PS Ratio1.62
PB Ratio3.85
Price to Fair Value3.85
Price to FCF26.40
Price to Operating Cash Flow-14.55
PEG Ratio-2.57
Income Statement
In the last 12 months, EZZ Life Science Holdings Ltd. had revenue of 66.87M and earned 6.73M in profits. Earnings per share was 0.15.
Revenue66.87M
Gross Profit49.72M
Operating Income9.93M
Pretax Income10.59M
Net Income6.73M
EBITDA11.10M
Earnings Per Share (EPS)0.15
Cash Flow
In the last 12 months, operating cash flow was -2.62M and capital expenditures -72.25K, giving a free cash flow of -2.69M billion.
Operating Cash Flow-2.62M
Free Cash Flow-2.69M
Free Cash Flow per Share-0.06
Dividends & Yields
EZZ Life Science Holdings Ltd. pays an annual dividend of AU$0.02, resulting in a dividend yield of 2.81%
Dividend Per ShareAU$0.02
Dividend Yield2.81%
Payout Ratio27.40%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.87
52-Week Price Change-40.04%
50-Day Moving Average1.32
200-Day Moving Average1.98
Relative Strength Index (RSI)25.51
Average Volume (3m)49.70K
Important Dates
EZZ Life Science Holdings Ltd. upcoming earnings date is Sep 2, 2026, Before Open (Confirmed).
Last Earnings DateFeb 27, 2026
Next Earnings DateSep 2, 2026
Ex-Dividend Date―
Financial Position
EZZ Life Science Holdings Ltd. as a current ratio of 5.77, with Debt / Equity ratio of 0.45%
Current Ratio5.77
Quick Ratio5.35
Debt to Market Cap<0.01
Net Debt to EBITDA-1.85
Interest Coverage Ratio356.76
Taxes
In the past 12 months, EZZ Life Science Holdings Ltd. has paid 3.86M in taxes.
Income Tax3.86M
Effective Tax Rate0.36
Enterprise Valuation
EZZ Life Science Holdings Ltd. EV to EBITDA ratio is 7.88, with an EV/FCF ratio of 21.38.
EV to Sales1.31
EV to EBITDA7.88
EV to Free Cash Flow21.38
EV to Operating Cash Flow20.10
Balance Sheet
EZZ Life Science Holdings Ltd. has AU$13.47M in cash and marketable securities with AU$123.86K in debt, giving a net cash position of AU$13.35M billion.
Cash & Marketable SecuritiesAU$13.47M
Total DebtAU$123.86K
Net CashAU$13.35M
Net Cash Per ShareAU$0.28
Tangible Book Value Per ShareAU$0.61
Margins
Gross margin is 68.32%, with operating margin of 14.85%, and net profit margin of 10.06%.
Gross Margin68.32%
Operating Margin14.85%
Pretax Margin15.83%
Net Profit Margin10.06%
EBITDA Margin16.60%
EBIT Margin15.84%
Analyst Forecast
The average price target for EZZ Life Science Holdings Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast0.65%
EPS Growth Forecast-9.90%